Form 4 for INM InMed Pharmaceuticals Inc.
Accepted 2021-09-29 00:00:00 ET · period of report 2021-09-28 · accession 0001213900-21-050522 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-29 | 2021-09-28 | INM | ADAMS ERIC A | Pres, CEO, Dir | P - Purchase | $1.75 | +11.4K | 27.5K | +71% | +$19.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-28 | P | A | 11,400 | $1.75 | 27,483 | D | — | — |